Lightweight Adaptive and Recoverable Implants (LARI) for Chronic Single and Dual Neuropixels 2.0 Recordings for Naturalistic Behaviors in Feature-Rich Environments

preprint OA: closed
Full text JSON View at publisher
Full text 1,835 characters · extracted from oa-doi-fallback · click to expand
Abstract Understanding the neural mechanisms underlying naturalistic decision-making requires chronic, high-quality neural recordings from distributed brain regions in freely behaving animals. However, existing silicon probe implants for mice are limited by weight, fragility, lack of independent probe adjustment, and poor suitability for long-term recordings in complex environments. Here we introduce LARI-1.0 (Lightweight Adjustable and Reusable Implant) and LARI-mini, two Neuropixels 2.0 implant systems designed for stable, recoverable, and independently adjustable single- and dual-probe recordings in mice. LARI-1.0 enables independent vertical and lateral positioning of two probes, while LARI-mini provides a lighter single-probe alternative, reducing implant mass by ~20%. Fully assembled weights of ~2.3 g (LARI-1.0) and ~1.5 g (LARI-mini) remain within 10% and 7.5% of adult male mouse body weight, respectively. We validated implant performance in a custom feature-rich naturalistic foraging environment that elicited full-body movements, rapid elevation changes, and ethological foraging behaviors across fed, fasted, and high-fat diet states. Both implants exhibited excellent mechanical stability, minimal motion-related artifacts, and probe drift comparable to previous studies. High-quality single-unit activity with stable waveform features, 5–6× signal-to-noise ratios, and no systematic loss of well-isolated units was maintained for up to 180 days. These results demonstrate that LARI-1.0 and LARI-mini provide lightweight, durable, and customizable implant solutions enabling long-term, high-fidelity neural recordings during naturalistic behavior. Competing Interest Statement CG is a co-founder and/or has financial interests in Storyline Health Inc., DepoIQ Inc., and Rubicon AI Inc., and Primordial AI Inc.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00